Related references
Note: Only part of the references are listed.Molecular and clinical characterization o PTPN2 expression from RNA-seq data of 996 brain gliomas
Peng-fei Wang et al.
JOURNAL OF NEUROINFLAMMATION (2018)
PTPN2 Regulates Inflammasome Activation and Controls Onset of Intestinal Inflammation and Colon Cancer
Marianne R. Spalinger et al.
CELL REPORTS (2018)
PTPN2 as a promoter of colon carcinoma via reduction of inflammasome activation
Marianne R. Spalinger et al.
MOLECULAR & CELLULAR ONCOLOGY (2018)
Restraining reactive oxygen species in Listeria monocytogenes promotes the apoptosis of glial cells
Sen Li et al.
REDOX REPORT (2017)
ROS-modulated therapeutic approaches in cancer treatment
Muhammad Hassan Raza et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2017)
In vivo CRISPR screening identifies Ptpn2 as a cancer immunotherapy target
Robert T. Manguso et al.
NATURE (2017)
The Roles of ROS in Cancer Heterogeneity and Therapy
Paulo Luiz de Sa Junior et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2017)
Genetic variants of PTPN2 are associated with lung cancer risk: a re-analysis of eight GWASs in the TRICL-ILCCO consortium
Yun Feng et al.
SCIENTIFIC REPORTS (2017)
ROS and Brain Gliomas: An Overview of Potential and Innovative Therapeutic Strategies
Mariagrazia Rinaldi et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
Loss of protein tyrosine phosphatase, non-receptor type 2 is associated with activation of AKT and tamoxifen resistance in breast cancer
Elin Karlsson et al.
BREAST CANCER RESEARCH AND TREATMENT (2015)
ROS and Autophagy: Interactions and Molecular Regulatory Mechanisms
Lulu Li et al.
CELLULAR AND MOLECULAR NEUROBIOLOGY (2015)
Protein Tyrosine Phosphatase Nonreceptor Type 2 An Important Regulator of lnterleukin-6 Production in Rheumatoid Arthritis Synovial Fibroblasts
Borbala Aradi et al.
ARTHRITIS & RHEUMATOLOGY (2015)
PTPN2 controls differentiation of CD4+ T cells and limits intestinal inflammation and intestinal dysbiosis
M. R. Spalinger et al.
MUCOSAL IMMUNOLOGY (2015)
Chemotherapy plus radiotherapy versus radiotherapy alone in patients with anaplastic glioma: a systematic review and meta-analysis
Lei Zhang et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2013)
Reactive oxygen species-responsive miR-210 regulates proliferation and migration of adipose-derived stem cells via PTPN2
J. H. Kim et al.
CELL DEATH & DISEASE (2013)
Targeting EGF receptor variant III: tumor-specific peptide vaccination for malignant gliomas
Catherine A. Del Vecchio et al.
EXPERT REVIEW OF VACCINES (2012)
A restricted cell population propagates glioblastoma growth after chemotherapy
Jian Chen et al.
NATURE (2012)
Protein tyrosine phosphatase N2 regulates TNFα- induced signalling and cytokine secretion in human intestinal epithelial cells
Michael Scharl et al.
GUT (2011)
Mutation analysis of the tyrosine phosphatase PTPN2 in Hodgkin's lymphoma and T-cell non-Hodgkin's lymphoma
Maria Kleppe et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2011)
T cell protein tyrosine phosphatase attenuates T cell signaling to maintain tolerance in mice
Florian Wiede et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Exciting New Advances in Neuro-Oncology The Avenue to a Cure for Malignant Glioma
Erwin G. Van Meir et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2010)
Protein Tyrosine Phosphatase Non-Receptor Type 2 Regulates IFN-γ-Induced Cytokine Signaling in THP-1 Monocytes
Michael Scharl et al.
INFLAMMATORY BOWEL DISEASES (2010)
The 2007 WHO classification of tumours of the central nervous system
David N. Louis et al.
ACTA NEUROPATHOLOGICA (2007)
H2O2-induced cell death in human glioma cells:: Role of lipid peroxidation and PARP activation
YW Lee et al.
NEUROCHEMICAL RESEARCH (2001)
Share Paper
